Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study

Currently, little in-depth evidence is known about the application of extracorporeal membrane oxygenation (ECMO) therapy in coronavirus disease 2019 (COVID-19) patients. This retrospective multicenter cohort study included patients with COVID-19 at 7 designated hospitals in Wuhan, China. The patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Jing, Li, Rui, Chen, Yue, Qin, Juan-juan, Hu, Ming, Huang, Chao-lin, Cheng, Lin, He, Yi, Li, Yi, Zhou, Qiang, Zhou, Dai-xing, Huang, Fei, Lei, Fang, Yang, Bo, Chen, Jun, Deng, Hong-ping, Yuan, Yu-feng, Xia, Jia-hong, Wan, Song, Li, Hong-liang, Wei, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Huazhong University of Science and Technology 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881911/
https://www.ncbi.nlm.nih.gov/pubmed/33582899
http://dx.doi.org/10.1007/s11596-021-2311-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881911/
https://www.ncbi.nlm.nih.gov/pubmed/33582899
http://dx.doi.org/10.1007/s11596-021-2311-8

Ejemplares similares